HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Levofloxacin hydrochloride

HCID 9908810
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
177325-13-2
Standard SMILES
C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.Cl
InChIKey
CAOOISJXWZMLBN-PPHPATTJSA-N
Molecular formula
C18H21ClFN3O4
Average molar mass
397.8 g/mol
Monoisotopic mass
397.120462

Names & identifiers

Preferred name
Levofloxacin hydrochloride
IUPAC
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;hydrochloride
English name
Levofloxacin hydrochloride
Molecular formula
C18H21ClFN3O4
Molecular weight
397.83

Names & synonyms

Levofloxacin hydrochloride177325-13-2WeilisuUNII-HTN0D03VRZHTN0D03VRZDTXSID804327097H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, monohydrochloride, (S)-LEVOFLOXACIN HYDROCHLORIDE [WHO-DD]RefChem:153205DTXCID50383537LEVOFLOXACIN HCLC18H21ClFN3O4
Show more names
D8-Levofloxacin HClLevofloxacin hydrochcarboxylic acid monohydrochlorideLevofloxacin hydrochloride CP2015Levofloxacin hydrochloride hemihydrateLevofloxacin white powder Antibacterial-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)usp27 99% Levofloxacin white powder Antibacterial4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)-methyl)-7H-pyrrolo[2
(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochlorideLevofloxacin (hydrochloride)MFCD03265511(-)-Ofloxacin hydrochloride(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;hydrochloride7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrochloride (1:1), (3S)-Weilisu; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Monohydrochloride; (3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Monohydrochloride;Levofloxacinhydrochloride

Properties

Computed structural propertiesFilling in

Topological polar surface area
73.3 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
8
Rotatable bonds
2
Heavy atoms
27
Formal charge
0
Complexity
634

Physicochemical properties

storage temp.
2 · under inert gas (nitrogen or Argon) at 2-8°C
solubility
Aqueous Base (Slightly), DMSO (Slightly, Heated), Methanol (Slightly)
form
Solid
color
White to Pale Beige
InChI
InChI=1/C18H20FN3O4.ClH/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21;/h7-8,10H,3-6,9H2,1-2H3,(H,24,25);1H/t10-;/s3
InChIKey
CAOOISJXWZMLBN-MEQOOBBNNA-N
SMILES
O=C1C(=CN2[C@@H](C)COC3C(N4CCN(C)CC4)=C(F)C=C1C=32)C(=O)O.Cl |&1:5,r|
FDA UNII
0 D03VRZ · HTN0D03VRZ
HS Code
29349990 · 29349990

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

hs_code
29349990

Chemistry & industry

Applications

UsesLevofloxacin Hydrochloride is a fluoroquinolone broad spectrum antibiotic. It is an inhibitor of two enzymes, DNA gyrase and topoisomerase IV.

Preparation methods · 1 item

PreparationThe existing synthesis process for levofloxacin hydrochloride involves a condensation reaction of levofluorocarboxylic acid and N-methylpiperazine under a catalyst to produce levofloxacin. The solvent is then evaporated, and the product is crystallized in a crystallization solvent and dried to obtain dried levofloxacin. Finally, levofloxacin is salted with hydrochloric acid and crystallized multiple times with ethanol to obtain levofloxacin hydrochloride. The existing synthesis process has the following problems: 1) It requires the prior preparation of levofloxacin crystals before salting with hydrochloric acid, making the process lengthy, cumbersome, and difficult to operate; 2) The use of a catalyst in the preparation of levofloxacin introduces impurities, resulting in low purity of the final levofloxacin hydrochloride, requiring further purification.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
177325-13-2
PubChem CID
9908810
DTXSID
DTXSID80432709
ChEMBL
CHEMBL2237108
UNII
HTN0D03VRZ
EC Number
605-797-4